Colloidally Stable Monodisperse Fe Nanoparticles as T-2
Contrast Agents for High-Field Clinical and Preclinical
Magnetic Resonance Imaging

J 2021

Colloidally Stable Monodisperse Fe Nanoparticles as T-2 Contrast Agents for High-Field Clinical and Preclinical Magnetic Resonance Imaging

DASH, A., B. BLASIAK, Boguslaw TOMANEK, A. BANERJEE, S. TRUDEL et. al.

Basic information

Original name

Colloidally Stable Monodisperse Fe Nanoparticles as T-2 Contrast Agents for High-Field Clinical and Preclinical Magnetic Resonance Imaging

Authors

DASH, A., B. BLASIAK, Boguslaw TOMANEK (616 Poland, belonging to the institution), A. BANERJEE, S. TRUDEL, Peter LATTA (703 Slovakia, guarantor, belonging to the institution) and F.C.J.M. VAN VEGGEL

Edition

ACS Applied Nano Materials, Washington, D.C. American Chemical Society, 2021, 2574-0970

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10305 Fluids and plasma physics

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 6.140

RIV identification code

RIV/00216224:14740/21:00124303

Organization unit

Central European Institute of Technology

DOI

http://dx.doi.org/10.1021/acsanm.0c02848

UT WoS

000624546800032

Keywords in English

iron; nanoparticle; MRI; T-2 contrast; transverse relaxivity; magnetization; 3 T; 9.4 T

Abstract

V originále

Iron nanoparticles (Fe NPs) produce negative contrast in magnetic resonance imaging (MRI) by shortening the transverse relaxation time (T-2) of water protons at tissue sites. The high sensitivity of Fe toward oxidation under ambient conditions has challenged and impeded the development of stable Fe NPs for bioapplications compared to iron oxide nanoparticles (IONPs). This article demonstrates the synthesis of three batches of fairly monodisperse (size dispersion, <10%), colloidal Fe NPs with inorganic core diameters of 15.2, 12.0, and 8.8 nm. The 15.2 nm Fe NPs show high stability against oxidation, beyond 5 months, when dispersed in chloroform and deionized water. Upon dispersion in deionized water, these NPs gradually develop an amorphous iron oxide shell. On the contrary, upon transfer into water, the smaller Fe NPs oxidize to amorphous iron oxide eventually. The 15.2 nm Fe NPs exhibit much stronger shortening of the T-2 relaxation time compared to the 12.0 and 8.8 nm Fe NPs at both high-field clinical 3 T and preclinical 9.4 T. The transverse relaxivity (r(2)) values of the 15.2 nm Fe NPs, based on per Fe ion concentration, were determined to be 167.9 mM(-1) s(-1) at 3 T and 236.4 mM(-1) s(-1) (higher than similarly sized IONPs) at 9.4 T. The respective r(2)/r(1) ratios of 280 and 788 are high for a T-2 contrast agent, although comprehensive MRI data for Fe NPs are not available in the literature for direct comparison. Fe NPs are promising MRI contrast agents for medical imaging.

Links

90129, large research infrastructures

Name: Czech-BioImaging II

Citovat

DASH, A., B. BLASIAK, Boguslaw TOMANEK, A. BANERJEE, S. TRUDEL, Peter LATTA and F.C.J.M. VAN VEGGEL. Colloidally Stable Monodisperse Fe Nanoparticles as T-2 Contrast Agents for High-Field Clinical and Preclinical Magnetic Resonance Imaging. ACS Applied Nano Materials. Washington, D.C.: American Chemical Society, 2021, vol. 4, No 2, p. 1235-1242. ISSN 2574-0970. Available from: https://dx.doi.org/10.1021/acsanm.0c02848.

@article{1837286,
   author = {Dash, A. and Blasiak, B. and Tomanek, Boguslaw and Banerjee, A. and Trudel, S. and Latta, Peter and van Veggel, F.C.J.M.},
   article_location = {Washington, D.C.},
   article_number = {2},
   doi = {http://dx.doi.org/10.1021/acsanm.0c02848},
   keywords = {iron; nanoparticle; MRI; T-2 contrast; transverse relaxivity; magnetization; 3 T; 9.4 T},
   language = {eng},
   issn = {2574-0970},
   journal = {ACS Applied Nano Materials},
   title = {Colloidally Stable Monodisperse Fe Nanoparticles as T-2 Contrast Agents for High-Field Clinical and Preclinical Magnetic Resonance Imaging},
   url = {https://pubs.acs.org/doi/10.1021/acsanm.0c02848},
   volume = {4},
   year = {2021}
}

TY  - JOUR
ID  - 1837286
AU  - Dash, A. - Blasiak, B. - Tomanek, Boguslaw - Banerjee, A. - Trudel, S. - Latta, Peter - van Veggel, F.C.J.M.
PY  - 2021
TI  - Colloidally Stable Monodisperse Fe Nanoparticles as T-2 Contrast Agents for High-Field Clinical and Preclinical Magnetic Resonance Imaging
JF  - ACS Applied Nano Materials
VL  - 4
IS  - 2
SP  - 1235-1242
EP  - 1235-1242
PB  - American Chemical Society
SN  - 25740970
KW  - iron
KW  - nanoparticle
KW  - MRI
KW  - T-2 contrast
KW  - transverse relaxivity
KW  - magnetization
KW  - 3 T
KW  - 9.4 T
UR  - https://pubs.acs.org/doi/10.1021/acsanm.0c02848
N2  - Iron nanoparticles (Fe NPs) produce negative contrast in magnetic resonance imaging (MRI) by shortening the transverse relaxation time (T-2) of water protons at tissue sites. The high sensitivity of Fe toward oxidation under ambient conditions has challenged and impeded the development of stable Fe NPs for bioapplications compared to iron oxide nanoparticles (IONPs). This article demonstrates the synthesis of three batches of fairly monodisperse (size dispersion, <10%), colloidal Fe NPs with inorganic core diameters of 15.2, 12.0, and 8.8 nm. The 15.2 nm Fe NPs show high stability against oxidation, beyond 5 months, when dispersed in chloroform and deionized water. Upon dispersion in deionized water, these NPs gradually develop an amorphous iron oxide shell. On the contrary, upon transfer into water, the smaller Fe NPs oxidize to amorphous iron oxide eventually. The 15.2 nm Fe NPs exhibit much stronger shortening of the T-2 relaxation time compared to the 12.0 and 8.8 nm Fe NPs at both high-field clinical 3 T and preclinical 9.4 T. The transverse relaxivity (r(2)) values of the 15.2 nm Fe NPs, based on per Fe ion concentration, were determined to be 167.9 mM(-1) s(-1) at 3 T and 236.4 mM(-1) s(-1) (higher than similarly sized IONPs) at 9.4 T. The respective r(2)/r(1) ratios of 280 and 788 are high for a T-2 contrast agent, although comprehensive MRI data for Fe NPs are not available in the literature for direct comparison. Fe NPs are promising MRI contrast agents for medical imaging.
ER  -

DASH, A., B. BLASIAK, Boguslaw TOMANEK, A. BANERJEE, S. TRUDEL, Peter LATTA and F.C.J.M. VAN VEGGEL. Colloidally Stable Monodisperse Fe Nanoparticles as T-2 Contrast Agents for High-Field Clinical and Preclinical Magnetic Resonance Imaging. \textit{ACS Applied Nano Materials}. Washington, D.C.: American Chemical Society, 2021, vol.~4, No~2, p.~1235-1242. ISSN~2574-0970. Available from: https://dx.doi.org/10.1021/acsanm.0c02848.

Detailed Information on Publication Record